ALYSSA LUCAS: Open Payments
NPI 1114561453 · WEST LAKE HILLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 27 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $135 |
| Alkermes, Inc. | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Neos Therapeutics, LP | 3 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Lundbeck LLC | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: TRINTELLIX, LYBALVI, Auvelity, Adzenys XR-ODT, REXULTI, INGREZZA, CAPLYTA, FANAPT.
Industry payments across TX — which companies pay providers there.
